Revision Total Knee Arthroplasty
10
2
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.0%
1 terminated out of 10 trials
66.7%
-19.8% vs benchmark
10%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee
IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA
ATTUNE Revision System in the Revision Total Knee Arthroplasty Population
Gut Microbiome in Orthopaedics: Revision Total Knee Arthroplasty
Multigen Plus CCK and AMF TT Cones Follow Up Study
PMCF Study on the Safety, Performance and Clinical Benefits Data of the NexGen TM Augmentation Patella
Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty
Adductor Canal Block (ACB) vs Femoral Nerve Block (FNB) in Revision Total Knee Arthroplasty
Tranexamic Acid in Revision Total Joint Arthroplasty
Tissue Culture Versus Swab Culture in Prosthetic Joint Infections